Appropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancer

Affiliations

¹ Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, University of Washington Schools of Medicine, Public Health, and Pharmacy, Seattle, WA glyman@fhcrc.org.

Editorial

Gary H Lyman. J Clin Oncol. 2015.

. 2015 Jan 20;33(3):232-4.

doi: 10.1200/JCO.2014.58.9838. Epub 2014 Dec 8.

¹ Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, University of Washington Schools of Medicine, Public Health, and Pharmacy, Seattle, WA glyman@fhcrc.org.

No abstract available

Comment on

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.
Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A. Boileau JF, et al. J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452445 Clinical Trial.